innerbanner

Home > General > VertigoHeel 100 tab by HEEL

VertigoHeel 100 tab by HEEL

VertigoHeel 100 tab by HEEL

VERTIGOHEELâ Shown to be Safe and Effective in the Treatment of Vertigo

ALBUQUERQUE, N.M., August 13, 1998 — A study published in the August issue of the American Medical Association journal Archives of Otolaryngology - Head and Neck Surgery shows that VERTIGO HEEL , a prescription homeopathic medication, is as effective and safe as betahistine, a histamine analogue considered standard therapy in Europe for the management of vertigo symptoms.

The publication of this study in an AMA journal reflects the growing interest in homeopathic medicine.

In fact, in the July 15, 1998 issue of the Journal of the American Medical Association (JAMA), a survey of readers identified "alternative medicine" such as homeopathy, as one of the top ten topics of which more information should be published.

Vestibular or balance disorders such as vertigo, dizziness, and motion sickness affect approximately two million people in the U.S. Despite the severity of vertigo, American physicians lack a conventional medication proven to be an effective treatment for the disease.

This study represents the first equivalence trial comparing a homeopathic treatment for vertigo to standard drug therapy.

"This is the first time that the AMA has published a study of a homeopathic drug - a study that was designed according to modern scientific methodology," said Dana Ullman, MPH, president of the Foundation for Homeopathic Education and Research and author of numerous books on homeopathy. "Other respected, peer-reviewed medical publications such as The Lancet, Pediatrics and British Medical Journal are now joined by the AMA’s Archives of Otolaryngology in their scientific review of homeopathic studies."

The year-long, double-blind, randomized, controlled clinical trial compared the efficacy and safety of VERTIGo HEEL with betahistine. The study included 119 male and female patients with acute or chronic vertigo symptoms of various origins.

The clinical trial was conducted from 1995 to 1996 at 15 medical clinics throughout Germany. In accordance with good clinical practices, patients were assigned to one of two treatment groups: the VERTIGO HEEL group or the betahistine group. Patients in both groups were given

15 drops three times per day of the active drug (VERTIG HEEL or betahistine) for 42 consecutive days.



Dimensions: 1x2x3

Price: $25.81

quantity: 

QTY:

Sku :1302340

Having trouble finding the product you're looking for? We can find it! E-mail sales@bbpharmacy.com.